Related Experiment Video
Updated: Mar 28, 2026

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
Mevalonate Pathway Regulates Cell Size Homeostasis and Proteostasis through Autophagy
Teemu P Miettinen1, Mikael Björklund1
1Division of Cell and Developmental Biology, School of Life Sciences, University of Dundee, DD1 5EH Dundee, Scotland, UK.
Abstract:
Balance between cell growth and proliferation determines cell size homeostasis, but little is known about how metabolic pathways are involved in the maintenance of this balance. Here, we perform a screen with a library of clinically used drug molecules for their effects on cell size. We find that statins, inhibitors of the mevalonate pathway, reduce cell proliferation and increase cell size and cellular protein density in various cell types, including primary human cells. Mevalonate pathway effects on cell size and protein density are mediated through geranylgeranylation of the small GTPase RAB11, which is required for basal autophagic flux. Our results identify the mevalonate pathway as a metabolic regulator of autophagy and expose a paradox in the regulation of cell size and proteostasis, where inhibition of an anabolic pathway can cause an increase in cell size and cellular protein density.
Insights
Statins, used to inhibit the mevalonate pathway, decrease cell proliferation and increase cell size and protein density. This occurs via geranylgeranylation of RAB11, regulating autophagy and cell size homeostasis.
Area of Science:
- Cell Biology
- Metabolic Pathways
- Drug Discovery
Background:
- Cell size homeostasis relies on balancing cell growth and proliferation.
- The role of metabolic pathways in maintaining this balance is not well understood.
Purpose of the Study:
- To investigate the effects of clinically used drugs on cell size.
- To identify metabolic regulators of cell size and proteostasis.
Main Methods:
- Screening a library of clinical drug molecules for their impact on cell size.
- Utilizing various cell types, including primary human cells.
- Investigating the role of geranylgeranylation and the small GTPase RAB11.
Main Results:
- Statins, inhibitors of the mevalonate pathway, were found to reduce cell proliferation.
- Statins increased cell size and cellular protein density across multiple cell types.
- Mevalonate pathway's influence on cell size and protein density is mediated by RAB11 geranylgeranylation, impacting autophagic flux.
Conclusions:
- The mevalonate pathway is identified as a key metabolic regulator of autophagy.
- Inhibition of an anabolic pathway paradoxically leads to increased cell size and protein density, highlighting complex regulation of proteostasis.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

